Acetylcarnitine and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetylcarnitine (acetyl - l - carnitine) and Gabapentin (gabapentin). Common drug interactions include skin ulcer among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Acetylcarnitine and Gabapentin. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Acetylcarnitine?

Acetylcarnitine has active ingredients of acetyl - l - carnitine. eHealthMe is studying from 418 Acetylcarnitine users. Check the latest studies of Acetylcarnitine.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

37 people who take Acetylcarnitine and Gabapentin together, and have interactions are studied.

Acetylcarnitine and Gabapentin drug interactions.

What are the common drug interactions of Acetylcarnitine and Gabapentin, by gender? *:

female:

  1. Skin ulcer
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Tendonitis (a condition that causes pain and swelling of tendons)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Balance disorder
  6. Bone pain
  7. Catheter site infection (infection at the site of insertion)
  8. Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
  9. Cough
  10. Facial bones fracture (bone fracture of face)

male:

  1. Back pain
  2. Fatigue (feeling of tiredness)
  3. Abnormal dreams
  4. Chronic kidney disease
  5. Cough
  6. Diarrhoea
  7. Duodenitis (inflammation of the duodenum)
  8. Dysuria (painful or difficult urination)
  9. Gastritis (inflammation of stomach)
  10. Haematuria (presence of blood in urine)

What are the common drug interactions of Acetylcarnitine and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Abnormal dreams
  3. Back pain
  4. Chronic kidney disease
  5. Cough
  6. Diarrhoea
  7. Duodenitis (inflammation of the duodenum)
  8. Dysuria (painful or difficult urination)
  9. Gastritis (inflammation of stomach)
  10. Haematuria (presence of blood in urine)

50-59:

  1. Blood pressure increased
  2. Fatigue (feeling of tiredness)
  3. Arrhythmia (irregular heartbeat)
  4. Back pain
  5. Chest pain
  6. Epistaxis (bleed from the nose)
  7. Hospitalisation
  8. Neck pain
  9. Weight increased
  10. Blood glucose increased

60+:

  1. Back pain
  2. Burning sensation
  3. Balance disorder
  4. Bone pain
  5. Catheter site infection (infection at the site of insertion)
  6. Constipation
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Cough
  9. Dizziness
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 45.95%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 29.73%
  3. Pain: 5 people, 13.51%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 10.81%
  5. Immunodeficiency Common Variable: 4 people, 10.81%
  6. Stress And Anxiety: 2 people, 5.41%
  7. Drowsiness: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Acetylcarnitine and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetylcarnitine and Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetylcarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetylcarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetyl - l - carnitine and gabapentin (the active ingredients of Acetylcarnitine and Gabapentin, respectively), and Acetylcarnitine and Gabapentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: